These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21231837)

  • 41. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.
    Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; de Leeuw PW; Peeters LL
    J Soc Gynecol Investig; 2005 Feb; 12(2):112-7. PubMed ID: 15695106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two successful pregnancies following eight miscarriages in a patient with antithrombin deficiency.
    Szilágyi A; Nagy A; Tamás P; Vizer M; Szabó I; Losonczy H
    Gynecol Obstet Invest; 2006; 61(2):111-4. PubMed ID: 16244492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science?
    Larciprete G; Rossi F; Deaibess T; Brienza L; Barbati G; Romanini E; Gioia S; Cirese E
    J Obstet Gynaecol Res; 2010 Oct; 36(5):996-1002. PubMed ID: 20868443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulant therapy and thromboprophylaxis in patients with thrombophilia.
    Weintraub AY; Sheiner E
    Arch Gynecol Obstet; 2007 Dec; 276(6):567-71. PubMed ID: 17828548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inherited thrombophilia and pregnancy complications revisited.
    Rodger MA; Paidas M; McLintock C; Middeldorp S; Kahn S; Martinelli I; Hague W; Rosene Montella K; Greer I
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):320-4. PubMed ID: 18669729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thrombophilia and pregnancy].
    Carlizza A
    Minerva Cardioangiol; 2006 Dec; 54(6):799-801. PubMed ID: 17393610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjusting enoxaparin dosage according to anti-FXa levels and pregnancy outcome in thrombophilic women. A randomised controlled trial.
    Salim R; Nachum Z; Gavish I; Romano S; Braverman M; Garmi G
    Thromb Haemost; 2016 Sep; 116(4):687-95. PubMed ID: 27440463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High frequency of congenital thrombophilia in women with pathological pregnancies?
    Rasmussen A; Ravn P
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):808-17. PubMed ID: 15315591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
    Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
    Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].
    Barjot P; Beucher G; Le Querrec A; Derlon-Borel A; Herlicoviez M
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):544-9. PubMed ID: 10598348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes.
    Sabadell J; Casellas M; Alijotas-Reig J; Arellano-Rodrigo E; Cabero L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):47-51. PubMed ID: 20047788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombophilia and pregnancy complications.
    Vormittag R; Pabinger I
    Hamostaseologie; 2006 Jan; 26(1):59-62. PubMed ID: 16444325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Usefulness of a scoring system on perinatal outcomes in pregnant women with thrombophilia in the effectiveness of an enoxaparin-based intervention].
    Figueiró-Filho EA; de Oliveira VM; Breda I; Coelho LR; Ferreira CM
    Rev Bras Ginecol Obstet; 2012 Oct; 34(10):459-65. PubMed ID: 23288223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor V Leiden in pregnancies complicated by placental abruption.
    Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
    BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombophilia and adverse pregnancy outcome.
    Mousa HA; Alfirević Z
    Croat Med J; 2001 Apr; 42(2):135-45. PubMed ID: 11259734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.